PT965339E - Composicao de nateglinida em comprimidos - Google Patents

Composicao de nateglinida em comprimidos

Info

Publication number
PT965339E
PT965339E PT97912459T PT97912459T PT965339E PT 965339 E PT965339 E PT 965339E PT 97912459 T PT97912459 T PT 97912459T PT 97912459 T PT97912459 T PT 97912459T PT 965339 E PT965339 E PT 965339E
Authority
PT
Portugal
Prior art keywords
nateglinide
tablets
composition
meals
carboxymethyl cellulose
Prior art date
Application number
PT97912459T
Other languages
English (en)
Inventor
Yabuki Akira
Kaida Masato
Ando Takahiko
Ninomiya Nobutaka
Ozaki Masanao
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18100283&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT965339(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of PT965339E publication Critical patent/PT965339E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PT97912459T 1996-11-15 1997-11-14 Composicao de nateglinida em comprimidos PT965339E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31854196 1996-11-15

Publications (1)

Publication Number Publication Date
PT965339E true PT965339E (pt) 2006-06-30

Family

ID=18100283

Family Applications (2)

Application Number Title Priority Date Filing Date
PT05014497T PT1586314E (pt) 1996-11-15 1997-11-14 Composição de comprimidos de nateglinida
PT97912459T PT965339E (pt) 1996-11-15 1997-11-14 Composicao de nateglinida em comprimidos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT05014497T PT1586314E (pt) 1996-11-15 1997-11-14 Composição de comprimidos de nateglinida

Country Status (14)

Country Link
US (4) US6143323A (pt)
EP (3) EP1586314B1 (pt)
JP (1) JP4171091B2 (pt)
KR (1) KR100343062B1 (pt)
CN (1) CN1245158C (pt)
AT (2) ATE503472T1 (pt)
AU (1) AU718350B2 (pt)
CA (1) CA2271865C (pt)
DE (2) DE69735644T2 (pt)
DK (1) DK1586314T3 (pt)
ES (2) ES2257772T3 (pt)
PT (2) PT1586314E (pt)
TW (1) TW492878B (pt)
WO (1) WO1998022105A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022105A1 (fr) * 1996-11-15 1998-05-28 Ajinomoto Co., Inc. Preparation en comprimes
EP1121103B1 (en) 1998-05-18 2006-12-20 Takeda Pharmaceutical Company Limited Orally disintegrable tablets comprising a benzimidazole
DK1561458T3 (da) * 1998-07-28 2010-10-25 Takeda Pharmaceutical Hurtigt henfaldende fast middel
JP2000119160A (ja) * 1998-10-06 2000-04-25 Kanebo Ltd 皮膚化粧料
US6878749B2 (en) 1999-09-17 2005-04-12 Novartis Ag Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
CO5200844A1 (es) * 1999-09-17 2002-09-27 Novartis Ag Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
US6559188B1 (en) 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
PL356300A1 (en) 1999-12-28 2004-06-28 Ajinomoto Co, Inc. Oral preparations for diabetes
WO2001068136A1 (fr) * 2000-03-17 2001-09-20 Ajinomoto Co., Inc. Medicaments permettant de traiter les complications du diabete et des neuropathies et utilisation de ces medicaments
PT1334963E (pt) * 2000-10-18 2007-09-20 Ajinomoto Kk Processo para a produção de cristais de nateglinida
DK1334962T3 (da) 2000-10-18 2007-12-10 Ajinomoto Kk Fremgangsmåder til fremstilling af acylphenylalanin
ES2288997T3 (es) * 2000-10-24 2008-02-01 Ajinomoto Co., Inc. Procedimiento para producir cristales de nateglinida de tipo b.
CA2426263C (en) * 2000-10-24 2010-05-25 Ajinomoto Co., Inc. Nateglinide-containing preparation
CA2426764C (en) * 2000-10-24 2010-04-20 Ajinomoto Co., Inc. Nateglinide-containing hydrophilic pharmaceutical preparation
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
JP2003252749A (ja) * 2002-03-04 2003-09-10 Shin Etsu Chem Co Ltd 外用基剤
US6830759B2 (en) 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
CN1247194C (zh) * 2002-08-27 2006-03-29 石药集团中奇制药技术（石家庄）有限公司 一种那格列奈包合物
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
KR100882156B1 (ko) 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제
WO2005016315A1 (en) * 2003-08-14 2005-02-24 Ranbaxy Laboratories Limited Pharmaceutical compositions of nateglinide and a high amount of a water-soluble filler
WO2005094812A1 (ja) * 2004-04-01 2005-10-13 Ajinomoto Co., Inc. ナテグリニド含有製剤
WO2005117840A1 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising pulverized granules of nateglinide of form b
EP1776102A1 (en) * 2004-07-28 2007-04-25 Ranbaxy Laboratories Limited Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation
ATE401868T1 (de) * 2004-08-04 2008-08-15 Alza Corp ZUSAMMENSETZUNG MIT VERZÖGERTER ARZNEIMITTELFREISETZUNG MIT EINEM AUFSTEIGENDEN NULLORDNUNG-FREIGABE-MUSTER; VERFAHREN ZUR HERSTELLUNG EINER SOLCHEN ZUSAMMENSETZUNGß
KR20070058540A (ko) * 2004-10-01 2007-06-08 니폰 조키 세야쿠 가부시키가이샤 고형 의약제제
US7276198B2 (en) * 2004-12-28 2007-10-02 The Goodyear Tire & Rubber Company Method and mold for making tire with tie bar
KR20070102694A (ko) * 2005-01-31 2007-10-19 아지노모토 가부시키가이샤 혈당 강하제를 함유하는, 내당능 이상, 경계형 당뇨병,인슐린 저항성 및 고인슐린혈증 개선 또는 치료용 의약조성물
TWI482641B (zh) * 2006-12-07 2015-05-01 Daiichi Sankyo Co Ltd 含有低取代度羥丙基纖維素之醫藥組成物
TWI428151B (zh) * 2006-12-07 2014-03-01 Daiichi Sankyo Co Ltd 含有甘露醇或乳糖之固形製劑
CA2672157C (en) * 2006-12-07 2016-07-26 Daiichi Sankyo Company, Limited Method for producing solid preparation
US20100280064A1 (en) * 2006-12-07 2010-11-04 Tomoyuki Watanabe Pharmaceutical composition having improved storage stability
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
ES2100291T3 (es) 1991-07-30 1997-06-16 Ajinomoto Kk Cristales de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina y metodos para prepararlos.
JPH07503236A (ja) * 1991-11-26 1995-04-06 ワーナー−ランバート・コンパニー 制御放出性ジェムフィブロジル剤形の開発のための方法および組成物
WO1998022105A1 (fr) * 1996-11-15 1998-05-28 Ajinomoto Co., Inc. Preparation en comprimes

Also Published As

Publication number Publication date
CA2271865A1 (en) 1998-05-28
US20030147951A1 (en) 2003-08-07
PT1586314E (pt) 2011-07-01
US6143323A (en) 2000-11-07
ATE322260T1 (de) 2006-04-15
DE69735644T2 (de) 2007-05-03
CA2271865C (en) 2003-10-14
AU718350B2 (en) 2000-04-13
KR100343062B1 (ko) 2002-07-02
CN1245158C (zh) 2006-03-15
EP1586314A1 (en) 2005-10-19
US20020028239A1 (en) 2002-03-07
DK1586314T3 (da) 2011-06-20
JPH10194969A (ja) 1998-07-28
ATE503472T1 (de) 2011-04-15
US6641841B2 (en) 2003-11-04
TW492878B (en) 2002-07-01
EP0965339B1 (en) 2006-04-05
CN1242704A (zh) 2000-01-26
EP0965339A1 (en) 1999-12-22
ES2257772T3 (es) 2006-08-01
EP1586314B1 (en) 2011-03-30
AU4965497A (en) 1998-06-10
US6844008B2 (en) 2005-01-18
DE69735644D1 (de) 2006-05-18
ES2364145T3 (es) 2011-08-25
JP4171091B2 (ja) 2008-10-22
EP0965339A4 (en) 2003-04-23
WO1998022105A1 (fr) 1998-05-28
EP2277517A1 (en) 2011-01-26
DE69740161D1 (de) 2011-05-12
US6296872B1 (en) 2001-10-02
KR20000053312A (ko) 2000-08-25

Similar Documents

Publication Publication Date Title
PT965339E (pt) Composicao de nateglinida em comprimidos
DK0913156T3 (da) Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
MY118164A (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
ES2123903T3 (es) Composicion nutritiva conteniendo fibra.
DK420385D0 (da) Antioestrogent laegemiddel til perkutan indgift
ATE83651T1 (de) Acetylcystein enthaltende mundloesliche arzneimittel.
MX9100246A (es) Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion
PT991424E (pt) Composicoes farmaceuticas compreendendo um inibidor de redutase de aldose e um inibidor de ace
DE69727494D1 (de) Tablette
IS2234B (is) Samsetning til að bæla fráhvarfseinkenni og fíkn í áfengi hjá áfengissjúklingum og fyrirbyggja misnotkun áfengis hjá heilbrigðum einstaklingum
KR970706831A (ko) 당뇨병 치료용 약제 조성물(medicinal composition for diabetes)
EP1108429A3 (en) An improved amino acid composition for providing an amino acid supplement or protein substitute, particularly for the treatment and/or management of certain diseases
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
ID21038A (id) Tablet yang mengandung resin penukar anion
CN1092059C (zh) 一种治疗弓形虫病的药物
US6683098B1 (en) Use of drug miglitol (Glyset) for treatment of obesity to prevent weight gain for losing weight and for weight control
DK162471C (da) Suge- eller tyggetablet
CA1179267A (en) Composition for relieving toothache pain
RU94030887A (ru) N-ацетил-дегидрофенилаланил-l-метионин
KR890003375A (ko) 암로디핀의 베실레이트 염
BG95403U (bg) Състав на лекарствено средство с антихипертензивно действие
KR20040006092A (ko) 진주가루를 함유하는 아름다운 피부촉진제
KR890014121A (ko) 사람의 골공증(骨孔症) 치료를 위한 방법과 조성물